A novel pathway for receptor-mediated post-translational activation of inducible nitric oxide synthase

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 2, 2011, Pages 258-269

  Brovkovych, Viktor ^a   Zhang, Yongkang ^a   Brovkovych, Svitlana ^a   Minshall, Richard D ^a   Skidgel, Randal A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

ACE inhibitors; Endothelial cells; Inducible nitric oxide synthase; Kinin B1 receptor; Nitric oxide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; BETA ADRENERGIC RECEPTOR KINASE; BRADYKININ B1 RECEPTOR; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; FLAVONOID; GUANINE NUCLEOTIDE BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

ARTICLE; BIOSYNTHESIS; CELL LINE; CELL STRAIN HEK293; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BETA-ADRENERGIC RECEPTOR KINASES; CELL LINE; CYTOKINES; ENALAPRILAT; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FLAVONOIDS; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PYRIMIDINES; RECEPTOR, BRADYKININ B1; SRC-FAMILY KINASES; TRANSFECTION;

EID: 79951864902     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00992.x     Document Type: Article

References (41)

1. Papapetropoulos A, Rudic RD, Sessa WC. Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res. 1999; 43: 509-20.
2. Dudzinski DM, Igarashi J, Greif D, et al The regulation and pharmacology of endothelial nitric oxide synthases. Annu Rev Pharmacol Toxicol. 2006; 46: 235-76.
3. Maniatis NA, Brovkovych V, Allen SE, et al Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res. 2006; 99: 870-7.
4. Kone BC, Kuncewicz T, Zhang W, et al Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide. Am J Physiol Renal Physiol. 2003; 285: F178-90.
5. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem. 2003; 384: 1343-64.
6. Forstermann U, Gath I, Schwarz P, et al Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol. 1995; 50: 1321-32.
7. Mitchell DA, Erwin PA, Michel T, et al S-Nitrosation and regulation of inducible nitric oxide synthase. Biochemistry. 2005; 44: 4636-47.
8. Yoshida M, Xia Y. Heat shock protein 90 as an endogenous protein enhancer of inducible nitric-oxide synthase. J Biol Chem. 2003; 278: 36953-8.
9. Kolodziejska KE, Burns AR, Moore RH, et al Regulation of inducible nitric oxide synthase by aggresome formation. Proc Natl Acad Sci USA. 2005; 102: 4854-9.
10. Hausel P, Latado H, Courjault-Gautier F, et al Src-mediated phosphorylation regulates subcellular distribution and activity of human inducible nitric oxide synthase. Oncogene. 2006; 25: 198-206.
11. Tyryshkin A, Gorgun FM, Abdel Fattah E, et al SRC kinase-mediated phosphorylation stabilizes iNOS in normal and in cancer cells. J Biol Chem. 2009; doi.
12. Sangsree S, Brovkovych V, Minshall RD, et al Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists. Am J Physiol Heart Circ Physiol. 2003; 284: H1959-68.
13. Ignjatovic T, Stanisavljevic S, Brovkovych V, et al Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands. Mol Pharmacol. 2004; 66: 1310-6.
14. Stanisavljevic S, Ignjatovic T, Deddish PA, et al Angiotensin I-converting enzyme inhibitors block protein kinase C{epsilon} by activating bradykinin b1 receptors in human endothelial cells. J Pharmacol Exp Ther. 2006; 316: 1153-8.
15. Zhang Y, Brovkovych V, Brovkovych S, et al Dynamic receptor-dependent activation of inducible nitric-oxide synthase by ERK-mediated phosphorylation of Ser745. J Biol Chem. 2007; 282: 32453-61.
16. Marjanovic JA, Stojanovic A, Brovkovych VM, et al Signaling-mediated functional activation of inducible nitric oxide synthase and its role in stimulating platelet activation. J Biol Chem. 2008; 283: 28827-34.
17. Shajahan AN, Tiruppathi C, Smrcka AV, et al Gβγ activation of Src induces caveolae-mediated endocytosis in endothelial cells. J Biol Chem. 2004; 279: 48055-62.
18. Brovkovych V, Stolarczyk E, Oman J, et al Direct electrochemical measurement of nitric oxide in vascular endothelium. J Pharm Biomed Anal. 1999; 19: 135-43.
19. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, et al International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005; 57: 27-77.
20. Closs EI, Scheld JS, Sharafi M, et al Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol. 2000; 57: 68-74.
21. Goubaeva F, Ghosh M, Malik S, et al Stimulation of cellular signaling and G protein subunit dissociation by G protein betagamma subunit-binding peptides. J Biol Chem. 2003; 278: 19634-41.
22. van Biesen T, Hawes BE, Luttrell DK, et al Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature. 1995; 376: 781-4.
23. Greco S, Storelli C, Marsigliante S. Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin. J Endocrinol. 2006; 188: 79-89.
24. Ignjatovic T, Tan F, Brovkovych V, et al Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor. J Biol Chem. 2002; 277: 16847-52.
25. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev. 1992; 44: 1-80.
26. Skidgel RA, Erdös EG. Cellular carboxypeptidases. Immunol Rev. 1998; 161: 129-41.
27. Zhang X, Tan F, Zhang Y, et al Carboxypeptidase M and kinin B1 receptors interact to facilitate efficient B1 signaling from B2 agonists. J Biol Chem. 2008; 283: 7994-8004.
28. Venema RC. Post-translational mechanisms of endothelial nitric oxide synthase regulation by bradykinin. Int Immunopharmacol. 2002; 2: 1755-62.
29. Goldsmith ZG, Dhanasekaran DN. G protein regulation of MAPK networks. Oncogene. 2007; 26: 3122-42.
30. Blaukat A. Structure and signalling pathways of kinin receptors. Andrologia. 2003; 35: 17-23.
31. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by {beta}-arrestins. Science. 2005; 308: 512-7.
32. Campos MM, Leal PC, Yunes RA, et al Non-peptide antagonists for kinin B1 receptors: new insights into their therapeutic potential for the management of inflammation and pain. Trends Pharmacol Sci. 2006; 27: 646-51.
33. Pesquero JB, Bader M. Genetically altered animal models in the kallikrein-kinin system. Biol Chem. 2006; 387: 119-26.
34. Kakoki M, McGarrah RW, Kim HS, et al Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury. Proc Natl Acad Sci USA. 2007; 104: 7576-81.
35. Siebeck M, Spannagl E, Schorr M, et al Effect of combined B1 and B2 kinin receptor blockade in porcine endotoxin shock. Immunopharmacology. 1996; 33: 81-4.
36. Xu J, Carretero OA, Shesely EG, et al The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice. Exp Physiol. 2009; 94: 322-9.
37. Couture R, Girolami J-P. Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur J Pharmacol. 2004; 500: 467-85.
38. Skidgel RA, Stanisavljevic S, Erdös EG. Kinin- and angiotensin-converting enzyme (ACE) inhibitor-mediated nitric oxide production in endothelial cells. Biol Chem. 2006; 387: 159-65.
39. Goldspink PH, Montgomery DE, Walker LA, et al Protein kinase Cepsilon overex-pression alters myofilament properties and composition during the progression of heart failure. Circ Res. 2004; 95: 424-32.
40. Chan GC, Fish JE, Mawji IA, et al Epigenetic basis for the transcriptional hyporesponsiveness of the human inducible nitric oxide synthase gene in vascular endothelial cells. J Immunol. 2005; 175: 3846-61.
41. Merino VF, Todiras M, Campos LA, et al Increased susceptibility to endotoxic shock in transgenic rats with endothelial overexpression of kinin B(1) receptors. J Mol Med. 2008; 86: 791-8.